{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:57:56Z","timestamp":1792508276981,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":946,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1111\/jth.14720","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T21:10:30Z","timestamp":1577135430000},"page":"926-930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Prevalence of confirmed antiphospholipid syndrome in 18\u201050 years unselected patients with first unprovoked venous thromboembolism"],"prefix":"10.1016","volume":"18","author":[{"given":"Sebastien","family":"Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Le Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavash","family":"Piran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shemina","family":"Kherani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Rodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0227-1245","authenticated-orcid":false,"given":"Aur\u00e9lien","family":"Delluc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1111\/jth.14720_bb0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11239-015-1316-1","article-title":"Guidance for the evaluation and treatment of hereditary and acquired thrombophilia","volume":"41","author":"Stevens","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1111\/jth.14720_bb0015","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"6","key":"10.1111\/jth.14720_bb0020","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1503\/cmaj.733532","article-title":"Thrombophilia testing in venous thromboembolism","volume":"190","author":"Rehman","year":"2018","journal-title":"CMAJ"},{"issue":"13","key":"10.1111\/jth.14720_bb0025","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high\u2010risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1111\/jth.14720_bb0030","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome. A population\u2010based study","volume":"71","author":"Duarte\u2010Garc\u00eda","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1111\/jth.14720_bb0035","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/acr.22066","article-title":"Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature","volume":"65","author":"Andreoli","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1111\/jth.14720_bb0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0961203309360541","article-title":"Update on anti\u2010phospholipid antibodies in SLE: the Hopkins\u2019 Lupus Cohort","volume":"19","author":"Petri","year":"2010","journal-title":"Lupus"},{"key":"10.1111\/jth.14720_bb0045","article-title":"Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism","author":"Stephen","year":"2019","journal-title":"Haematologica"},{"issue":"2","key":"10.1111\/jth.14720_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1111\/jth.14720_bb0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1182\/asheducation-2011.1.150","article-title":"Is thrombophilia testing useful?","volume":"2011","author":"Middeldorp","year":"2011","journal-title":"Hematology"},{"issue":"5","key":"10.1111\/jth.14720_bb0060","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/jth.12537","article-title":"Testing for Antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH","volume":"12","author":"Devreese","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1111\/jth.14720_bb0065","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1111\/jth.14720_bb0070","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"10.1111\/jth.14720_bb0075","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high\u2010risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"Pengo","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.14720_bb0080","unstructured":"Apixaban for the secondary prevention of thromboembolism among patients with the antiphospholipid syndrome (ASTRO\u2010APS) [NCT02295475]:US National Library of Medicine. [Internet]. https:\/\/clinicaltrials.gov\/ct2\/history\/NCT02295475?A=1&B=10&C=Side-by-Side#StudyPageTop. Accessed June 12, 2019."},{"issue":"5","key":"10.1111\/jth.14720_bb0085","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.pathol.2017.12.344","article-title":"Prevalence of antiphospholipid antibodies in an Australian cohort of patients with unprovoked venous thromboembolism","volume":"50","author":"Ho","year":"2018","journal-title":"Pathology"},{"issue":"1","key":"10.1111\/jth.14720_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000088541","article-title":"Long\u2010term prospective study of recurrent venous thromboembolism in patients younger than 50 years","volume":"34","author":"Garcia\u2010Fuster","year":"2005","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"7","key":"10.1111\/jth.14720_bb0095","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.3324\/haematol.2017.185132","article-title":"Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban","volume":"103","author":"Martinelli","year":"2018","journal-title":"Haematologica"},{"issue":"19","key":"10.1111\/jth.14720_bb0100","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1182\/blood-2017-09-805689","article-title":"Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism","volume":"131","author":"Kearon","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1111\/jth.14720_bb0105","doi-asserted-by":"crossref","first-page":"1701202","DOI":"10.1183\/13993003.01202-2017","article-title":"Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS\u2010PE randomised trial","volume":"51","author":"Tromeur","year":"2018","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1111\/jth.14720_bb0110","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients: clinical and immunologic manifestations of APS","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1111\/jth.14720_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.2015.7046","article-title":"Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: the PADIS\u2010PE randomized clinical trial","volume":"314","author":"Couturaud","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"10.1111\/jth.14720_bb0120","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/cmaj.080493","article-title":"Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy","volume":"179","author":"Rodger","year":"2008","journal-title":"Can Med Assoc J"},{"issue":"2","key":"10.1111\/jth.14720_bb0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"3","key":"10.1111\/jth.14720_bb0130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0038-1655986","article-title":"Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism\u2013results of the Spanish Multicentric Study on Thrombophilia (EMET\u2010Study)","volume":"77","author":"Mateo","year":"1997","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14720","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14720","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14720","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622002756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622002756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:28:23Z","timestamp":1761535703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622002756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1538783622002756"],"URL":"https:\/\/doi.org\/10.1111\/jth.14720","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of confirmed antiphospholipid syndrome in 18\u201050 years unselected patients with first unprovoked venous thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}